246
Participants
Start Date
February 16, 2017
Primary Completion Date
May 1, 2020
Study Completion Date
April 30, 2021
DOAC
DOAC is a blood thinning drug, also called direct oral anticoagulant. These group of drugs are approved by the U.S. Food and Drug Administration (FDA) for the treatment of stroke prophylaxis in atrial fibrillation and deep vein thrombosis and pulmonary embolism, which are blood clots in the veins or lungs.
Aspirin
Aspirin works by reducing substances in the body that cause pain, fever, and inflammation. Aspirin is used to treat pain, and reduce fever or inflammation.
Montefiore Medical Center, The Bronx
University of Kansas Medical Center, Kansas City
KCHRF, Overland Park
TCAI, Austin
Jayadeva Institute of Medical Sciences, Bengaluru
Kansas City Heart Rhythm Research Foundation
OTHER
Kansas City Heart Rhythm Institute
OTHER